Education
About Us
Working with TipRanks
Follow Us
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
PBSV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.31 - $0.70
Previous CloseN/A
Volume2.02K
Average Volume (3M)5.08K
Market Cap
$11.69M
Enterprise Value$6.25M
Total Cash (Recent Filing)$12.43M
Total Debt (Recent Filing)$153.99K
Price to Earnings (P/E)―
Beta-0.19
Next Earnings
Sep 10, 2025EPS Estimate
0.03Last Dividend Ex-Date
Feb 28, 2025Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding22,927,942
10 Day Avg. Volume10,234
30 Day Avg. Volume5,084
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)<0.01
Price to Sales (P/S)0.00
P/FCF Ratio-7.13
Enterprise Value/Market Cap0.53
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit2.27
Enterprise Value/Ebitda-2.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pharma Bio Services News
PremiumCompany Announcements
Pharma Bio Services Elects New Director at Annual Meeting
PremiumCompany Announcements
Pharma Bio Services: Incentive Plan Extended, Directors Elected
Options Prices
Currently, No data available
---
Ownership Overview
10.78%
Insiders
― Other Institutional Investors
89.22% Public Companies and
Individual Investors
PBSV FAQ
What was Pharma Bio Services’s price range in the past 12 months?
Pharma Bio Services lowest stock price was $0.31 and its highest was $0.70 in the past 12 months.
What is Pharma Bio Services’s market cap?
Pharma Bio Services’s market cap is $11.69M.
When is Pharma Bio Services’s upcoming earnings report date?
Pharma Bio Services’s upcoming earnings report date is Sep 10, 2025 which is in 79 days.
How were Pharma Bio Services’s earnings last quarter?
Pharma Bio Services released its earnings results on Jun 16, 2025. The company reported $0.03 earnings per share for the quarter, the consensus estimate of $0.03 by $0.
Is Pharma Bio Services overvalued?
According to Wall Street analysts Pharma Bio Services’s price is currently Overvalued.
Does Pharma Bio Services pay dividends?
Pharma Bio Services pays a Notavailable dividend of $0.075 which represents an annual dividend yield of N/A. See more information on Pharma Bio Services dividends here
What is Pharma Bio Services’s EPS estimate?
Pharma Bio Services’s EPS estimate is 0.03.
How many shares outstanding does Pharma Bio Services have?
Pharma Bio Services has 22,927,942 shares outstanding.
What happened to Pharma Bio Services’s price movement after its last earnings report?
Pharma Bio Services reported an EPS of $0.03 in its last earnings report, expectations of $0.03. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharma Bio Services?
Currently, no hedge funds are holding shares in PBSV
Company Description
Pharma Bio Services
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Technical Analysis
Streamline Health Solutions
―
Scienture Holdings
―
OneMedNet
―
Healthcare Triangle
―
BullFrog AI Holdings, Inc.
―